Related Experiment Video
Updated: Jul 27, 2026

Transport Properties of Ibuprofen Encapsulated in Cyclodextrin Nanosponge Hydrogels: A Proton HR-MAS NMR Spectroscopy Study
Published on: August 15, 2016
Acid-Sensitive Polypseudorotaxanes Based on Ortho Ester-Modified Cyclodextrin and Pluronic F-127
Ran Ji1, Jing Cheng1, Cheng-Cheng Song1
1Beijing National Laboratory for Molecular Sciences, Key Laboratory of Polymer Chemistry and Physics of Ministry of Education, College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, People's Republic of China.
Abstract:
We demonstrate a new type of acid-sensitive amphiphilic polypseudorotaxanes (PPRs) formed via inclusion complexation between Pluronic F127 and the hydrophobic β-cyclodextrin (CD) derivative in alcoholic solvents. The 6-OH ortho ester-substituted hydrophobic β-CD derivative (EMD-CD) was prepared by "click" reaction of β-CD with 2-ethylidene-4-methyl-1,3-dioxalane under mild conditions. The water-insoluble EMD-CD (host) is capable of forming PPRs with F127 (guest) in ethanol or methanol but not in water, which is confirmed by 1H NMR, wide-angle X-ray diffraction, small-angle X-ray scattering, and the time-dependent threading kinetics. Depending on the host/guest ratio, the PPRs self-assembled into sheet-like structure or vesicular nanoparticles with different sizes in water. These PPR assemblies were stable at pH 8.4 but quickly dissociated into biocompatible products in neutral or in acidic buffers due to the hydrolysis of the ortho ester groups. Good biocompatibility, ease of fabrication, and extremely pH-sensitive character make the PPRs promising carriers for anticancer drug delivery. Moreover, the present work provides an alternative method for the preparation of PPRs composed of water-insoluble CD derivatives.
More Related Videos
Related Concept Videos
Ion Exchange
Drugs for Treatment of Constipation-Predominant IBS
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Rate-Programmed I
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Oral Drug Delivery Systems: Delayed-Release Systems

